Filter by: patients
What is Strattera?

Strattera® is a brand name for the drug atomoxetine HCL, a selective norepinephrine reuptake inhibitor used in the treatment of attention deficit hyperactivity disorder (ADHD).

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
ADHD (Attention Deficit/Hyperactivity Disorder) 50 13 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Problems concentrating 22 8 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 15 4 Efficacy_major Efficacy_moderate Efficacy_none Efficacy_cant_tell
Depressed mood 7 1 Efficacy_major
Treat my mood condition(s) 6 2 Efficacy_major
ADD (Attention Deficit Disorder) 5 3 Efficacy_moderate

See all 68 patients currently taking Strattera

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
9
Moderate
12
Mild
5
None
9

Reported Dosages

Frequently reported dosages based on patients currently taking Strattera. See all 13 dosages

  10 mg daily 18 mg daily 25 mg daily 30 mg daily 40 mg daily 50 mg daily 60 mg daily 80 mg daily 100 mg daily 120 mg daily
  3 Number of Patients: 3 3 Number of Patients: 3 9 Number of Patients: 9 1 Number of Patients: 1 9 Number of Patients: 9 1 Number of Patients: 1 13 Number of Patients: 13 19 Number of Patients: 19 7 Number of Patients: 7 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Strattera (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 24   Did not seem to work: 46%
Side effects too severe 23   Side effects too severe: 44%
Other 11   Other: 21%
Doctor's advice 10   Doctor's advice: 19%
Expense 6   Expense: 12%
Course of treatment ended 2   Course of treatment ended: 4%
Change in health plan coverage 2   Change in health plan coverage: 4%
Not indicated 2   Not indicated: 4%
Personal research 1   Personal research: 2%

See all 50 patients who’ve stopped taking Strattera

Currently Taking Strattera

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Strattera

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Strattera

Always
22 63%
Usually
11 31%
Sometimes
2 6%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Strattera

Very
1 3%
Somewhat
6 17%
A little
8 23%
Not at all
20 57%

Cost

Paid out of pocket

Cost of Strattera

$200+
0 0%
$100-199
1 6%
$50-99
4 24%
$25-49
9 53%
< $25
3 18%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.